Product
Sibutramine
1 clinical trial
1 indication
Indication
ObesityClinical trial
An Open-label, Multicentre, Randomized Comparative Study to Evaluate the Efficacy and Safety of Using the Sibutramin-containing Drugs Reduxin® Forte and Reduxin® in Patients With Alimentary ObesityStatus: Completed, Estimated PCD: 2021-05-21